| BSE: 532649 | Sector: Health care |
| NSE: NECLIFE | ISIN Code: INE023H01027 |
| BSE 00:00 | 22 Jun | 24.05 |
-0.70 (-2.83%) |
OPEN
24.70 |
HIGH
24.70 |
LOW
23.50 |
| NSE 00:00 | 22 Jun | 24.05 |
-0.60 (-2.43%) |
OPEN
24.75 |
HIGH
24.75 |
LOW
23.05 |
| OPEN | 24.70 |
| PREVIOUS CLOSE | 24.75 |
| VOLUME | 34251 |
| 52-Week high | 41.75 |
| 52-Week low | 18.70 |
| P/E | 10.32 |
| Mkt Cap.(Rs cr) | 539 |
| Buy Price | 0.00 |
| Buy Qty | 0.00 |
| Sell Price | 0.00 |
| Sell Qty | 0.00 |
Nectar Lifesciences Ltd is an integrated pharmaceutical organization, engaged in manufacturing and delivering high quality pharmaceutical products. The company manufactures Cephalosporin Active pharmaceutical ingredients, finished dosage forms, Phytochemicals, and hard gelatin capsules at their facilities spread across three Indian states of Punjab, Himachal Pradesh and Jammu. They have developed ...> More
| COMPANY INFORMATION | |||||||
| Chairman & Managing Director : | Sanjiv Goyal | ||||||
| Independent Director : | Vijay J Shah | ||||||
| Independent Director : | Shamsher Singh Chauhan | ||||||
| Director : | Vivek Sett | ||||||
| Independent Director : | Ajay Swaroop | ||||||
| President & Director : | Harparkash Singh Gill | ||||||
| Director & Chief Executive Off : | Dinesh Dua | ||||||
| Independent Director : | Guljit Chaudhri | ||||||
| Company Secretary : | Ankita Jain | ||||||
| AUDITOR : | Shilpa Baldota & Associates | ||||||
| IND NAME : | Pharmaceuticals - Indian - Bulk Drugs | ||||||
| HOUSE NAME : | Indian Private | ||||||
| Registered office | |||||||
| Village Saidpura, Tehsil Derabassi,Mohali,Punjab- | |||||||
| Ph : 91-1762-308000/308001 | |||||||
| WEBSITE : http://www.neclife.com | |||||||
| E-mail : sunderlal@neclife.com | |||||||
